Back to search

Article

EGFR as a potent CAR T target in Triple Negative Breast Cancer Brain Metastases

2022-07-14

Abstract excerpt

<title>Abstract</title> <p><bold>Purpose</bold> There is currently no curative treatment for patients diagnosed with triple-negative breast cancer brain metastases (TNBC-BM). CAR T cells hold potential for curative treatment given they retain the cytolytic activity of a T cell combined with the specificity of an antibody. In this proposal we evaluated the potential of EGFR re-directed CAR T cells as a therapeutic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5b5b45c2-3a2e-5d3b-a443-c06c248d7afc
DOI
10.21203/rs.3.rs-1828989/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
EGFR as a potent CAR T target in Triple Negative Breast Cancer Brain MetastasesDOI 10.21203/rs.3.rs-1828989/v1
Select a neighboring publication to make it the new centre.